Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Lixiang Pharmaceutical is a comprehensive pharmaceutical enterprise based in Kunming, Yunnan Province, China. Established in 1998, the company specializes in the research, development, and large-scale production of both Traditional Chinese Medicine (TCM) and chemical drugs. Its product portfolio is primarily focused on cardiovascular and cerebrovascular health, leveraging Yunnan's unique botanical resources such as Erigeron breviscapus and Panax notoginseng. The company operates modern, GMP-certified manufacturing facilities and maintains a robust distribution network within the Chinese domestic market. Yunnan Lixiang is recognized for its integration of traditional herbal wisdom with modern pharmaceutical quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Lixiang Pharmaceutical.